Investor Relations task is to continuously provide the capital market with information about ChromoGenics operation and financial development. Please contact us if you have questions or comments.
- ChromoGenics receives new orders totaling approximately SEK 1.1 million October 5, 2021
- We are nominated for Glasspriset 2021! October 4, 2021
- Outcome of the first exercise period for ChromoGenics warrants of series 2020/2022:1 September 28, 2021
- Meet our new CEO Fredrik Fränding! September 22, 2021
- The first deliveries to an environmentally certified building in Oslo have left ChromoGenics factory in Uppsala September 3, 2021